Clinical trial
Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal…
NCT00406900 · Ludwig-Maximilians - University of Munich, Other · Unknown status
Key facts
| NCT number | NCT00406900 |
|---|---|
| Title | Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma |
| Lead sponsor | Ludwig-Maximilians - University of Munich, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Melanoma, Radiotherapy, Metastatic Disease |
| Intervention type | Procedure |
| Interventions | Treatment of metastatic disease |
| Enrollment | 560 |
| Start date | Jan 1, 1999 |
| Completion | Sep 1, 2006 |
| First posted | Dec 4, 2006 |
| Last update posted | Dec 6, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: